ReviewJournal of general internal medicine2003
Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.
Review in Journal of general internal medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial.Annals of family medicineTrial
- Equity in initial health evaluation utilization among world trade center health program members enrolled during 2012-2022.BMC health services research · 2025Article
- An Update on Gender Disparities in Coronary Heart Disease Care.Current atherosclerosis reports · 2016Review
- Goal attainments and their discrepancies for low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apo B) in over 2,000 Chinese patients with known coronary artery disease or type 2 diabetes.Cardiovascular diagnosis and therapy · 2015Article
- Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection.Digestive diseases and sciences · 2014Observational
- Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative.The Journal of continuing education in the health professions · 2014Article
- Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.Lipids in health and disease · 2011Article
- A taxonomy of reasons for not prescribing guideline-recommended medications for patients with heart failure.The American journal of geriatric pharmacotherapy · 2010Article
- Quality of cardiovascular disease preventive care and physician/practice characteristics.Journal of general internal medicine · 2006Article
- Gender disparities in patient education provided during patient visits with a diagnosis of coronary heart disease.Women's health (London, England)Observational
- Differences in cardiovascular disease risk factor management in primary care by sex of physician and patient.Annals of family medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Screening and treatment rates for dyslipidemia in populations at high risk for cardiovascular disease (CVD) are inappropriately low and rates among women may be lower than among men. We conducted a review of the literature for possible explanations of these observed gender differences and categorized the evidence in terms of a conceptual model that we describe. Factors related to physicians' attitudes and knowledge, the patient's priorities and characteristics, and the health care systems in which they interact are all likely to play important roles in determining screening rates, but are not well understood. Research and interventions that simultaneously consider the influence of patient, clinician, and health system factors, and particularly research that focuses on modifiable mechanisms, will help us understand the causes of the observed gender differences and lead to improvements in cholesterol screening and management in high-risk women. For example, patient and physician preferences for lipid and other CVD risk factor management have not been well studied, particularly in relation to other gender-specific screening issues, costs of therapy, and by degree of CVD risk; better understanding of how available health plan benefits interact with these preferences could lead to structural changes in benefits that might improve screening and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.